期刊文献+

组蛋白去乙酰化酶6抑制剂Tubastatin A对酒精依赖小鼠的条件性位置偏爱行为及海马基质金属蛋白酶-9 mRNA表达的影响 被引量:2

Effects of selective HDAC6 inhibitor tubastatin A on alcohol dependence CPP behavior and expression of MMP-9 in hippocampus of mice
原文传递
导出
摘要 目的研究选择性组蛋白去乙酰化酶6(histone deacetylase 6,HDAC6)抑制剂tubastatin A对酒精依赖小鼠的条件性位置偏爱(conditioned place preference,CPP)行为及海马组织中HDAC6和基质金属蛋白酶-9(matrix metalloproteinases,MMP-9)m RNA表达的影响。方法采用CPP基础值前测试剔除对某侧过度偏爱的小鼠。将36只8周龄SPF级雌性C57BL/6J小鼠随机均分为4组,分别为对照[生理盐水(含1%DMSO)]组、酒精依赖(2.0 g/kg)组、单纯tubastatin A(10mg/kg)组和tubastatin A干预(2.0 g/kg酒精+10 mg/kg tubastatin A)组,每组9只。小鼠于训练阶段第2、4、6、8、10天腹腔注射酒精(2.0 g/kg)后放入伴药箱,第3、5、7和9天腹腔注射等量生理盐水后放入非伴药箱,各停留30 min;采用腹腔注射方式进行染毒,染毒容量为0.01 ml/g;腹腔注射后小鼠放入中间箱,记录15 min在每侧停留时间。采用实时荧光定量PCR法检测小鼠海马组织HDAC6及MMP-9 m RNA的表达水平。结果在测试阶段,酒精依赖组和tubastatin A干预组小鼠在酒精侧停留时间显著高于对照组和单纯tubastatin A组(P<0.01)。与对照组相比,酒精依赖组小鼠出现明显CPP效应(P<0.05),单纯tubastatin A组小鼠CCP效应更加显著(P<0.01)。与对照组比较,单纯tubastatin A组和tubastatin A干预组小鼠海马区HDAC6 m RNA的表达水平显著下调(P<0.01)。与前测阶段比较,酒精依赖组小鼠海马区MMP-9的m RNA表达水平显著上调(P<0.05),tubastatin A干预组小鼠海马区MMP-9的m RNA表达水平的上调更为显著(P<0.01)。结论酒精可明显诱发C57BL/6J小鼠的CPP效应,给予Tubastatin A可增强这种效应。tubastatin A可能通过抑制海马组织HDAC6的表达来增强小鼠酒精依赖性CPP行为,这可能与HDAC6对MMP-9表达的调控有关。 Objective To investigate the effects of selective histone deacetylase 6 (HDAC6) inhibitor tubastatin A on alcohol dependence conditioned place preference (CPP) behavior and the expressions of HDAC6 and matrix metalloproteinases-9 (MMP-9) mRNA in hippocampus of mice. Methods Alcohol-CPP behaviors of mice were tested with conditioned place preference (CPP) video system. The mice excessive preference for one side were removed based on the baseline value. Thirty-six 8-week old C57BL/6J mice were divided equally into four groups: control group (normal saline containing 1% DMSO), alcohol dependence group(2.0 g/kg body weight), single tubastatin A group (10 mg/kg body weight) and tubastatin A intervention group (2.0 g/kg alcohol+10 mg/kg tubastatin A body weight), nine mice in each group. During the training process,on 2nd day ,4th day, 6th day and 8th day, the mice were placed in the drug-paired box after intra-peritoneal injection (i.p.) of alcohol (2.0 g/kg body weight);and on 3rd day , 5th day, 7th day and 9th day, mice were placed in the saline-paired box after i.p. with the same amount of normal sodium,stayed for 30 minutes,respectively. The toxicant exposures were intra-peritoneal injection,the volume of toxicant was 0.01 ml/g body weight. The mice were placed in the middle box after the i.p.,records residence time in each box for 15 minutes. Expressions of HDAC6 and MMP-9 mRNA in hippocampus of the mice were analyzed by real time- PCR. Results During the testing phase,the mice of alcohol dependence group and tubastatin A intervention group had significantly longer residence time in the alcohol side than control group and single tubastatin A treatment group (P〈0.01). Compared with the control group,the mice of alcohol dependence group presented CPP effect (P〈0.05) and single tubastatin A treatment group showed significantly strengthened CPP effect (P〈0.01). Compared with the control group,the expression of HDA C6 mRNA in single tubastatin A treatment group and tubastatin A intervention group were significantly down-regulated (P〈0.01). Compared with the pretesting phase,the expression of MMP-9 mRNA in alcohol dependence group was significantlyup-regulated (P〈0.05),and the expression of MMP-9 mRNA in single tubastatin A treatment group increased significantly (P〈 0.01). Conclusion Alcohol may induce obvious CPP effect in C57BL/6J mice,tubastatin A may significantly strengthen this effect. Tubastatin A may inhibit expression of HDAC6 in hippocampus of mice to enhance alcohol dependence CPP behavior, this may be related to the regulation of HDAC6 on expression of MMP-9.
出处 《环境与健康杂志》 CAS 北大核心 2015年第9期783-786,共4页 Journal of Environment and Health
基金 山西省青年科技研究基金(2013021022-1) 山西医科大学创新基金(01201402) 山西医科大学基础医学院331科技启动基金(201226)
关键词 酒精依赖 条件性位置偏爱 Tubastatin A 组蛋白去乙酰化酶6 基质金属蛋白酶 Alcohol dependence Conditioned place preference Tubastatin A HDAC6 MMP-9
  • 相关文献

参考文献21

  • 1Xu Z,Hou B,Gao Y,et al. Effects of enriched environment on morphine-induced reward in mice [ J ]. Exp Neurol, 2007,204: 714- 719.
  • 2柯钰婷,周文华.运动干预药物依赖的神经生物学机制研究进展[J].中国药理学与毒理学杂志,2015,29(4):599-606. 被引量:29
  • 3Tuesta EM,Zhang Y. Mechanisms of epigenetic memory and addiction [J ]. EMBO J,2014,33 : 1091-1103.
  • 4Crabbe JC. Neurogenetic studies of alcohol addiction [J]. Philos Trans R Soc Lond B Biol Sci,2008,363:3201-3211.
  • 5Zhang L, Sheng S, Qin C. The role of HDAC6 in Alzheimer' s disease [J ]. J Alzheimers Dis, 2013,33 : 283-295.
  • 6Zhou Z,Yuan Q,Mash DC,et al. Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol [J ]. Proc Natl Acad Sci USA, 2011,108:6626-6631.
  • 7朱慧,张薇,郭辰虹,张供,张维东,钟明,杨贵荣,葛志明,张运.心房肌基质金属蛋白酶-9和组织金属蛋白酶抑制因子-1表达改变对房颤心房重构机制的研究[J].中华医学杂志,2005,85(1):45-48. 被引量:30
  • 8Nishikawa N, Yamamoto K, Sakata Y, et al. Differential activation of matrixmetalloproteinases in heart failurewith andwithoutventricular dilatation [ J ]. Cardiovasc Res, 2003,57 : 766-774.
  • 9Kang MJ,Jung SA, Jung JM,et al. Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer [ J ]. Anticanc Res, 201 I, 31 : 575-584.
  • 10Samochowiec A, Grzywacz A, Kaczmarek L, et al. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study [J ]. Brain Res, 2010, 1327: 103-106.

二级参考文献85

  • 1Spinale FG, Coker ML, Bond BR, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart : a potential therapeutic target. Cardilvasc Res, 2000, 46:225-238.
  • 2Saharinen J, Hyytiainen M, Taipale J, et al. Latent transforming growth factor-beta binding proteins ( LTBPs ) structural extracellular nmtrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev, 1999, 10 : 99-117.
  • 3Peterson JT, Li H, Dillon L, et al. Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression int infracted rat. Cardiovasc Res, 2000, 46:307-315.
  • 4Nagahiro N, Kazuhiro Y, Yasushi S, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res, 2003, 57:766-774.
  • 5Ducharme A , Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest, 2000, 106:55-62.
  • 6Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metallproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure . Nat Med, 1999, 5:1135-1142.
  • 7Borg TK, Burgess ML. Holding it all together: organization and function(s) of the extracellular matrix of the heart. Heart Failure,1993,8 : 230-238.
  • 8Li YY, Feldman AM, Sun Y, et al. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.Circulation, 1998, 98 : 1728-1734.
  • 9Roten L, Nemoto S, Simsic J, et al. Effects of gene diletion of the tissue inhibitor of the matrix metalloproteinase-type 1 ( TIMP-1 ) on left ventricular geometry and function in mice. J Mol Cell Cardiol,2000, 32:109-120.
  • 10Volkow ND,Wang GJ,Fowler JS,Tomasi D.Addiction circuitry in the human brain[J].Annu Rev Pharmacol Toxicol,2012,52:321-336.

共引文献64

同被引文献18

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部